The new protocol utilizes Tri-Energy Synergy technology, which merges laser, radiofrequency, and ultrasound modalities through the proprietary BTS² Methodology. This system is engineered to target specific tissue depths across the epidermis, dermis, and subcutaneous layers, providing a more granular approach to anti-aging and skin contouring. Clinical focus remains on addressing diverse patient needs, ranging from skin texture refinement to structural firmness.

Eyal Ben David, CEO of Sisram Medical, described the launch as a pivotal milestone in the company’s evolution. He noted that the Hong Kong market, known for its mature aesthetic ecosystem and high demand for non-invasive procedures, serves as the primary hub for testing these integrated strategies before wider regional deployment. For clinic partners, the model offers a way to build signature service portfolios that differentiate them in a competitive landscape while maximizing cross-product efficiency.

As the medical aesthetics sector trends toward customized regimens, Sisram is positioning its portfolio to capitalize on this transition. The company intends to use the Hong Kong rollout as a operational benchmark, with plans to scale similar localized, multi-platform strategies across other key markets in the Asia-Pacific region.